TABLE 1.

Clinical symptom scores pre- and post-treatment

Symptoms	Group A (observation)			Group B (rabeprazole)			Group C (hydrotalcite)			Group D (combination)
	Pre	Post	P	Pre	Post	P	Pre	Post	P	Pre	Post	P
Epigastric pain	3.24±0.71	3.39±0.53	0.054	3.24±0.79	2.39±0.86	0.041*	3.32±0.08	2.06±1.00	0.033*	3.36±0.65	1.88±0.86	0.035*†
Heartburn	3.31±0.64	2.91±0.59	0.061	3.31±0.64	2.21±0.95	0.031*	3.23±0.69	1.96±0.07	0.026*	3.12±0.67	1.72±0.79	0.041*†
Bloating	3.27±0.86	3.10±0.94	0.093	3.22±0.71	2.16±0.91	0.029*	3.21±0.70	2.06±0.91	0.031*	3.25±0.68	1.69±1.01	0.022*†
Bitter taste	3.25±0.78	3.22±0.99	0.075	3.24±0.71	2.27±0.96	0.024*	3.29±0.73	2.16±0.92	0.013*	3.10±0.64	1.75±0.79	0.032*†

Pre- and post-treatment data presented as mean ± SD. Symptom scores ranged from 0 (not present) to 5 (very severe).

^*P<0.05 compared pre- and post-treatment in each group;

^†P<0.05 compared among the four groups